Evidence map›Paper›PMID 34910513›Full record

ArticleScience advances2021

MRE11-dependent instability in mitochondrial DNA fork protection activates a cGAS immune signaling pathway.

Jessica W Luzwick, Eszter Dombi, Rebecca A Boisvert, Sunetra Roy, Soyoung Park, Selvi Kunnimalaiyaan, Steffi Goffart, Detlev Schindler, Katharina Schlacher

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. The immunology behind inflammaging-causes, sources, and mechanisms.The Journal of allergy and clinical immunology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mitochondrial DNA signals driving immune responses: Why, How, Where?Cell communication and signaling : CCS · 2025
    Review
  10. Mitochondrial DNA in Exercise-Mediated Innate Immune Responses.International journal of molecular sciences · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. When DNA-damage responses meet innate and adaptive immunity.Cellular and molecular life sciences : CMLS · 2024
    Review
  18. Article
  19. Review
  20. DNA sensing of dendritic cells in cancer immunotherapy.Frontiers in molecular biosciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Jessica W LuzwickDepartment of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-6457-1457
Eszter DombiDepartment of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA.
Rebecca A BoisvertDepartment of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA.
Sunetra RoyDepartment of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA.
Soyoung ParkDepartment of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0003-2116-1893
Selvi KunnimalaiyaanDepartment of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0001-7519-272X
Steffi GoffartDepartment of Environmental and Biological Sciences, University of Eastern Finland, Joensuu, Finland.ORCID 0000-0001-8491-1458
Detlev SchindlerInstitut für Humangenetik, University of Würzburg, Würzburg, Germany.ORCID 0000-0003-2451-8165
Katharina SchlacherDepartment of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0001-7226-6391
The University of Texas MD Anderson Cancer Center · USUniversity of Eastern Finland · FIUniversity of Würzburg · DE

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Mechanism of RAD51C fork protection and environmental carcinogenesisR01ES029680 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SCHLACHER, KATHARINA · 2018 to 2022
$1.8M
NCI NIH HHS P30 CA016672NIEHS NIH HHS R01 ES029680
6 · The paper itself

Abstract

Mitochondrial DNA (mtDNA) instability activates cGAS-dependent innate immune signaling by unknown mechanisms. Here, we find that Fanconi anemia suppressor genes are acting in the mitochondria to protect mtDNA replication forks from instability. Specifically, Fanconi anemia patient cells show a loss of nascent mtDNA through MRE11 nuclease degradation. In contrast to DNA replication fork stability, which requires pathway activation by FANCD2-FANCI monoubiquitination and upstream FANC core complex genes, mitochondrial replication fork protection does not, revealing a mechanistic and genetic separation between mitochondrial and nuclear genome stability pathways. The degraded mtDNA causes hyperactivation of cGAS-dependent immune signaling resembling the unphosphorylated ISG3 response. Chemical inhibition of MRE11 suppresses this innate immune signaling, identifying MRE11 as a nuclease responsible for activating the mtDNA-dependent cGAS/STING response. Collective results establish a previously unknown molecular pathway for mtDNA replication stability and reveal a molecular handle to control mtDNA-dependent cGAS activation by inhibiting MRE11 nuclease.

Identifiers

PMID34910513
PMCPMC8673762
OpenAlexW4200048423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.